Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staging for liver cancer.

Bruno Daniele1, Francesco Perrone

  • 1Medical Oncology Unit, G. Rummo Hospital, Benevento, Italy. bruno.daniele@ao-rummo.it

Clinics in Liver Disease
|April 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM).

La Radiologia medica·2026
Same author

Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual Response.

Oncology research·2026
Same author

Golden rules for optimizing the diagnostic pathway of IDH-mutant tumors: bridging evidence and clinical practice in cholangiocarcinoma and adult-type diffuse gliomas.

Pathologica·2026
Same author

Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in Italy.

Oncology and therapy·2026
Same author

Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.

Liver cancer·2026
Same author

Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics Days.

Tumori·2026

This study explains how prognostic scores are developed and used for cancer patient management, differentiating them from staging systems. Prognostic scores are dynamic and can be updated with new data using proper methods.

Area of Science:

  • Oncology
  • Medical Statistics

Background:

  • Prognostic scores aid in cancer patient management and risk stratification.
  • Distinguishing prognostic scores from staging systems is crucial for clinical application.

Purpose of the Study:

  • To elaborate on the development and dynamic nature of prognostic scores.
  • To differentiate prognostic scores from staging systems.
  • To present and discuss prognostic systems specifically for hepatocellular carcinoma.

Main Methods:

  • Review of methodologies for developing and validating prognostic scores.
  • Comparative analysis of prognostic scores and staging systems.
  • Detailed presentation and discussion of existing prognostic systems for hepatocellular carcinoma.

Related Experiment Videos

Main Results:

  • Prognostic score development is an iterative and dynamic process.
  • Scores can be refined with new prognostic factors and validated methodologies.
  • Specific prognostic systems for hepatocellular carcinoma exhibit unique characteristics.

Conclusions:

  • Prognostic scores are essential, adaptable tools in cancer patient management.
  • Understanding the dynamic nature of scores allows for improved clinical decision-making.
  • Tailored prognostic systems are vital for optimizing hepatocellular carcinoma patient care.